An Act
ENROLLED SENATE
BILL NO. 136 By: Simpson of the Senate
and
Roe of the House
An Act relating to breast and cervical cance r;
amending 63 O.S. 2011, Section 1 -556, as amended by
Section 55, Chapter 229, O.S.L. 2013 (63 O.S. Supp.
2020, Section 1-556), which relates to annual report;
modifying time period of report; modifying criteria;
updating statutory refe rences and language; and
providing an effective date .
SUBJECT: Breast and cervical cance r
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
SECTION 1. AMENDATORY 63 O.S. 2011, Section 1 -556, as
amended by Section 55, Chapter 229, O.S.L. 2013 (63 O.S . Supp. 2020,
Section 1-556), is amended to read as follows:
Section 1-556. A. The State Department of Health, giving
consideration to the recommendations of the Advancement of Wellness
Advisory Council created in Section 44 of this act Section 1-103a.1
of this title, shall be responsible for evaluating and repo rting to
the Governor and the State Commissioner of Health regarding
contracting for statewide services or issues related to breast
cancer including, but not limited to:
1. Mammography and pap sme ar screening of women f or breast and
cervical cancer as an early detection health care measure, provided
by facilities which are accre dited by national organizations that
ENR. S. B. NO. 136 Page 2
have formed coalitions to issue national cancer screening
guidelines;
2. Medical referral of screened perso ns with abnormal breast
findings and, to the extent practical, for additional services or
assistance for such p ersons;
3. Education and training programs for health care
professionals to improve methods for the detection and control of
breast and cervical cancer, and to improve communicatio n with breast
and cervical cancer patients after diagnosis;
4. Annual public education and awareness campaigns to improve
the knowledge and health care practices of all Oklahomans with
respect to breast and cervical can cer;
5. Epidemiological trend studi es utilizing the data from the
Oklahoma Central Cancer Registry for inciden ce, prevalence and
survival of breast and cervical cancer victims; and
6. Outreach to groups with high proportions of uni nsured and
underinsured women.
B. The evaluative efforts o f the Advisory Committee with
respect to contracts for services specified i n subsection A of this
section shall provide appropriate oversight and require ments that
result in:
1. Enhanced quality c ontrol standards within facilities which
perform diagnostic cancer screening for breast and cervical cancer;
and
2. Establishment of a fee schedule for breast and cervical
cancer screening and diagnosis that com plies with accepted
Medicare/Medicaid rates and that incorporates a sliding fee payment
system to encourage self-responsibility.
C. The State Department of Health, giving consid eration to the
recommendations of the Advancement of Wellness Advisory Council
created in Section 44 of this act Section 1-103a.1 of this title,
shall report annually to the Governor, the Speaker of the House of
Representatives, the President Pro Tempore o f the Senate, and the
ENR. S. B. NO. 136 Page 3
State Board Commissioner of Health by October 1 of each year every
fifth year, beginning on October 1, 2021, activities completed
pursuant to the Oklahoma Breas t and Cervical Cancer Act during the
prior five (5) fiscal year, years including a report of the funding
for revolving funds expended on related activities. The report
shall may identify populations at highest risk for breast or
cervical cancer, priority strategies, and emerging technologies,
including newly introduced therapie s and preventive vaccines that
are effective in preventing and controlling the risk of breast and
cervical cancer, and any recommendations for ad ditional funding, if
necessary, to provide screenings and treatment for breast and
cervical cancer for uninsure d and underinsured women. The report
shall may further recommend strategies or actions to reduce the
costs of breast and cervical cancer in the State of Oklahoma this
state.
D. The Advancement of Wellness Advisory Council shall evaluate
the prospective termination or continuation of its ongoing duties on
October 1, 2008. Such eva luation shall be made based on the
successful implementation of breast and cervical cancer reduction
plans and/or achievement of significant reductions in breast and
cervical cancer morbidity and mortality in the State of Oklahoma
this state.
SECTION 2. This act shall become effecti ve October 1, 2021.
ENR. S. B. NO. 136 Page 4
Passed the Senate the 10th day of March, 2021.
Presiding Officer of the Senate
Passed the House of Represen tatives the 12th day of April, 2021.
Presiding Officer of the House
of Representatives
OFFICE OF THE GOVERNOR
Received by the Office of the Governor this _______ _____________
day of _______________ ____, 20_______, at _______ o'clock _______ M.
By: _______________________________ __
Approved by the Governor of the State of Oklahoma this _____ ____
day of _________________ __, 20_______, at _______ o'clock _______ M.
_________________________________
Governor of the State of Oklahoma
OFFICE OF THE SECRETARY OF STATE
Received by the Office of the Secretary of State this _______ ___
day of __________________, 20 _______, at _______ o'clock _______ M.
By: _______________________________ __